Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q1 2026 Earnings

19FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-5.08

-3.69

-2.29

-0.9

Details

Expected EPS

-0.895174

Actual EPS

-2.57

Surprise EPS

-1.67

Surprise Percent

+187.1%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -2.57 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.